Wilms' tumor: Reduced-dose radiotherapy in advanced-stage Wilms' tumor with favorable histology

Robert L. Tobin, James Fontanesi, Larry E. Kun, Diane L. Fairclough, H. Omar Hustu, William J. Pao, Edwin C. Douglass, Judith Wilimas, A. P. Mahesh Kumar, Jesse J. Jenkins

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Fifty-two children with favorable histology Wilms' tumor who had residual abdominal disease (Surgical Stages III and IV) were treated from 1979 to 1988 on a protocol designed to assess the effectiveness of reduced radiation doses. All patients received three-agent chemotherapy, beginning within 1 week after surgery. To permit assessment of disease response to initial chemotherapy, radiation therapy was delayed for a median of 28 days after surgery (range, 14-71 days). Total doses of abdominal radiation were limited to 12 Gy, given as 150 cGy daily fractions; 18 patients with Stage IV disease received 12 Gy bilateral pulmonary irradiation. Two year disease-free survival was 85% and 71% for Stage III and IV, respectively (p = .24). Abdominal relapses occurred in 3 cases (5.7%). The interval between surgery and initiation of irradiation was not related to disease-free survival. Of several patient and disease-related factors analyzed, only patient age was related to outcome. Disease-free survival was 100% at 3 years for children under the age of 3 versus 78% for children greater than age 3 (p = .05). Reduced-dose abdominal radiotherapy in conjunction with multi-agent chemotherapy and surgery provided excellent disease control with minimal toxicity in advanced-stage, favorable histology Wilms' tumor.

Original languageEnglish (US)
Pages (from-to)867-871
Number of pages5
JournalInternational Journal of Radiation Oncology, Biology, Physics
Volume19
Issue number4
DOIs
StatePublished - Jan 1 1990

Fingerprint

histology
Wilms Tumor
radiation therapy
Histology
Radiotherapy
tumors
dosage
Disease-Free Survival
surgery
chemotherapy
Drug Therapy
Radiation
Ambulatory Surgical Procedures
irradiation
radiation
Recurrence
Lung
toxicity
intervals

Keywords

  • Abdominal irradiation
  • Combination therapy
  • Wilms' tumor

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Radiation

Cite this

Wilms' tumor : Reduced-dose radiotherapy in advanced-stage Wilms' tumor with favorable histology. / Tobin, Robert L.; Fontanesi, James; Kun, Larry E.; Fairclough, Diane L.; Hustu, H. Omar; Pao, William J.; Douglass, Edwin C.; Wilimas, Judith; Mahesh Kumar, A. P.; Jenkins, Jesse J.

In: International Journal of Radiation Oncology, Biology, Physics, Vol. 19, No. 4, 01.01.1990, p. 867-871.

Research output: Contribution to journalArticle

Tobin, RL, Fontanesi, J, Kun, LE, Fairclough, DL, Hustu, HO, Pao, WJ, Douglass, EC, Wilimas, J, Mahesh Kumar, AP & Jenkins, JJ 1990, 'Wilms' tumor: Reduced-dose radiotherapy in advanced-stage Wilms' tumor with favorable histology', International Journal of Radiation Oncology, Biology, Physics, vol. 19, no. 4, pp. 867-871. https://doi.org/10.1016/0360-3016(90)90006-6
Tobin, Robert L. ; Fontanesi, James ; Kun, Larry E. ; Fairclough, Diane L. ; Hustu, H. Omar ; Pao, William J. ; Douglass, Edwin C. ; Wilimas, Judith ; Mahesh Kumar, A. P. ; Jenkins, Jesse J. / Wilms' tumor : Reduced-dose radiotherapy in advanced-stage Wilms' tumor with favorable histology. In: International Journal of Radiation Oncology, Biology, Physics. 1990 ; Vol. 19, No. 4. pp. 867-871.
@article{5116a5b9b4ab4e779714de989f7de4b1,
title = "Wilms' tumor: Reduced-dose radiotherapy in advanced-stage Wilms' tumor with favorable histology",
abstract = "Fifty-two children with favorable histology Wilms' tumor who had residual abdominal disease (Surgical Stages III and IV) were treated from 1979 to 1988 on a protocol designed to assess the effectiveness of reduced radiation doses. All patients received three-agent chemotherapy, beginning within 1 week after surgery. To permit assessment of disease response to initial chemotherapy, radiation therapy was delayed for a median of 28 days after surgery (range, 14-71 days). Total doses of abdominal radiation were limited to 12 Gy, given as 150 cGy daily fractions; 18 patients with Stage IV disease received 12 Gy bilateral pulmonary irradiation. Two year disease-free survival was 85{\%} and 71{\%} for Stage III and IV, respectively (p = .24). Abdominal relapses occurred in 3 cases (5.7{\%}). The interval between surgery and initiation of irradiation was not related to disease-free survival. Of several patient and disease-related factors analyzed, only patient age was related to outcome. Disease-free survival was 100{\%} at 3 years for children under the age of 3 versus 78{\%} for children greater than age 3 (p = .05). Reduced-dose abdominal radiotherapy in conjunction with multi-agent chemotherapy and surgery provided excellent disease control with minimal toxicity in advanced-stage, favorable histology Wilms' tumor.",
keywords = "Abdominal irradiation, Combination therapy, Wilms' tumor",
author = "Tobin, {Robert L.} and James Fontanesi and Kun, {Larry E.} and Fairclough, {Diane L.} and Hustu, {H. Omar} and Pao, {William J.} and Douglass, {Edwin C.} and Judith Wilimas and {Mahesh Kumar}, {A. P.} and Jenkins, {Jesse J.}",
year = "1990",
month = "1",
day = "1",
doi = "10.1016/0360-3016(90)90006-6",
language = "English (US)",
volume = "19",
pages = "867--871",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Wilms' tumor

T2 - Reduced-dose radiotherapy in advanced-stage Wilms' tumor with favorable histology

AU - Tobin, Robert L.

AU - Fontanesi, James

AU - Kun, Larry E.

AU - Fairclough, Diane L.

AU - Hustu, H. Omar

AU - Pao, William J.

AU - Douglass, Edwin C.

AU - Wilimas, Judith

AU - Mahesh Kumar, A. P.

AU - Jenkins, Jesse J.

PY - 1990/1/1

Y1 - 1990/1/1

N2 - Fifty-two children with favorable histology Wilms' tumor who had residual abdominal disease (Surgical Stages III and IV) were treated from 1979 to 1988 on a protocol designed to assess the effectiveness of reduced radiation doses. All patients received three-agent chemotherapy, beginning within 1 week after surgery. To permit assessment of disease response to initial chemotherapy, radiation therapy was delayed for a median of 28 days after surgery (range, 14-71 days). Total doses of abdominal radiation were limited to 12 Gy, given as 150 cGy daily fractions; 18 patients with Stage IV disease received 12 Gy bilateral pulmonary irradiation. Two year disease-free survival was 85% and 71% for Stage III and IV, respectively (p = .24). Abdominal relapses occurred in 3 cases (5.7%). The interval between surgery and initiation of irradiation was not related to disease-free survival. Of several patient and disease-related factors analyzed, only patient age was related to outcome. Disease-free survival was 100% at 3 years for children under the age of 3 versus 78% for children greater than age 3 (p = .05). Reduced-dose abdominal radiotherapy in conjunction with multi-agent chemotherapy and surgery provided excellent disease control with minimal toxicity in advanced-stage, favorable histology Wilms' tumor.

AB - Fifty-two children with favorable histology Wilms' tumor who had residual abdominal disease (Surgical Stages III and IV) were treated from 1979 to 1988 on a protocol designed to assess the effectiveness of reduced radiation doses. All patients received three-agent chemotherapy, beginning within 1 week after surgery. To permit assessment of disease response to initial chemotherapy, radiation therapy was delayed for a median of 28 days after surgery (range, 14-71 days). Total doses of abdominal radiation were limited to 12 Gy, given as 150 cGy daily fractions; 18 patients with Stage IV disease received 12 Gy bilateral pulmonary irradiation. Two year disease-free survival was 85% and 71% for Stage III and IV, respectively (p = .24). Abdominal relapses occurred in 3 cases (5.7%). The interval between surgery and initiation of irradiation was not related to disease-free survival. Of several patient and disease-related factors analyzed, only patient age was related to outcome. Disease-free survival was 100% at 3 years for children under the age of 3 versus 78% for children greater than age 3 (p = .05). Reduced-dose abdominal radiotherapy in conjunction with multi-agent chemotherapy and surgery provided excellent disease control with minimal toxicity in advanced-stage, favorable histology Wilms' tumor.

KW - Abdominal irradiation

KW - Combination therapy

KW - Wilms' tumor

UR - http://www.scopus.com/inward/record.url?scp=0025185056&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025185056&partnerID=8YFLogxK

U2 - 10.1016/0360-3016(90)90006-6

DO - 10.1016/0360-3016(90)90006-6

M3 - Article

C2 - 2170307

AN - SCOPUS:0025185056

VL - 19

SP - 867

EP - 871

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

SN - 0360-3016

IS - 4

ER -